Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HeartBeam, Inc. stock logo
BEAT
HeartBeam
$0.50
+0.1%
$0.62
$0.48
$4.00
$27.72M-0.78470,515 shs446,888 shs
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$36.32
-0.5%
$36.50
$33.27
$60.89
$104.71M0.725,128 shs1,587 shs
Pulmonx Corporation stock logo
LUNG
Pulmonx
$2.23
-7.9%
$1.54
$1.13
$2.89
$103.93M0.28881,869 shs440,076 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.51
-2.6%
$1.80
$1.45
$4.67
$104.11M1.06679,893 shs925,628 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HeartBeam, Inc. stock logo
BEAT
HeartBeam
+0.14%-8.89%-10.55%-45.41%-52.15%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
-0.52%-0.25%-4.70%-5.76%-32.82%
Pulmonx Corporation stock logo
LUNG
Pulmonx
-7.85%-2.19%+59.29%+66.42%+42.95%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-2.58%-21.96%-13.71%-12.72%-51.13%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HeartBeam, Inc. stock logo
BEAT
HeartBeam
$0.50
+0.1%
$0.62
$0.48
$4.00
$27.72M-0.78470,515 shs446,888 shs
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$36.32
-0.5%
$36.50
$33.27
$60.89
$104.71M0.725,128 shs1,587 shs
Pulmonx Corporation stock logo
LUNG
Pulmonx
$2.23
-7.9%
$1.54
$1.13
$2.89
$103.93M0.28881,869 shs440,076 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.51
-2.6%
$1.80
$1.45
$4.67
$104.11M1.06679,893 shs925,628 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HeartBeam, Inc. stock logo
BEAT
HeartBeam
+0.14%-8.89%-10.55%-45.41%-52.15%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
-0.52%-0.25%-4.70%-5.76%-32.82%
Pulmonx Corporation stock logo
LUNG
Pulmonx
-7.85%-2.19%+59.29%+66.42%+42.95%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-2.58%-21.96%-13.71%-12.72%-51.13%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HeartBeam, Inc. stock logo
BEAT
HeartBeam
2.67
Moderate Buy$4.00700.00% Upside
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
2.00
HoldN/AN/A
Pulmonx Corporation stock logo
LUNG
Pulmonx
2.50
Moderate Buy$7.67243.80% Upside
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2.80
Moderate Buy$6.38322.19% Upside

Current Analyst Ratings Breakdown

Latest BEAT, MBOT, KEQU, and LUNG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Reiterated RatingBuy$5.00 ➝ $4.00
7/22/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
UpgradeHoldStrong-Buy
7/14/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Reiterated RatingBuy
7/14/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
Initiated CoverageBuy$2.00
7/13/2026
Pulmonx Corporation stock logo
LUNG
Pulmonx
Reiterated RatingSell (E+)
7/8/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Reiterated RatingSell (D-)
7/2/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
Reiterated RatingSell (E+)
6/30/2026
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
Reiterated RatingHold (C)
6/3/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Set Price Target$4.00
5/22/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
Lower Price TargetBuy$5.50 ➝ $2.50
(Data available from 8/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/AN/AN/AN/A$0.06 per shareN/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$282M0.37$5.92 per share6.13$26.80 per share1.36
Pulmonx Corporation stock logo
LUNG
Pulmonx
$90.50M1.06N/AN/A$1.31 per share1.70
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$1.15 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-$21.01M-$0.51N/AN/AN/AN/A-686.78%-348.65%N/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$9.62M$3.2211.28N/AN/A3.41%14.10%5.55%9/16/2026 (Estimated)
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$54M-$1.16N/AN/AN/A-55.03%-96.66%-38.32%N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$13.14M-$0.24N/AN/AN/AN/A-21.87%-20.76%N/A

Latest BEAT, MBOT, KEQU, and LUNG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-$0.0860-$0.10-$0.0140-$0.10$0.15 million$0.10 million
8/11/2026Q2 2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.0767-$0.08-$0.0033-$0.08$0.13 million$0.24 million
7/29/2026Q2 2026
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.28-$0.24+$0.04-$0.24$22.39 million$22.76 million
6/23/2026Q4 2026
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
N/A$1.14N/A$1.13N/A$71.40 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/AN/AN/AN/AN/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
N/AN/AN/AN/AN/A
Pulmonx Corporation stock logo
LUNG
Pulmonx
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/A
3.66
3.61
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
0.53
2.18
1.55
Pulmonx Corporation stock logo
LUNG
Pulmonx
0.95
4.32
3.52
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
18.56
17.82

Institutional Ownership

CompanyInstitutional Ownership
HeartBeam, Inc. stock logo
BEAT
HeartBeam
7.77%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
32.69%
Pulmonx Corporation stock logo
LUNG
Pulmonx
91.04%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%

Insider Ownership

CompanyInsider Ownership
HeartBeam, Inc. stock logo
BEAT
HeartBeam
17.95%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
14.10%
Pulmonx Corporation stock logo
LUNG
Pulmonx
7.50%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
CompanyEmployeesShares OutstandingFree FloatOptionable
HeartBeam, Inc. stock logo
BEAT
HeartBeam
1,70055.51 million45.54 millionNot Optionable
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
1,2312.87 million2.46 millionNot Optionable
Pulmonx Corporation stock logo
LUNG
Pulmonx
25042.95 million39.73 millionOptionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2067.17 million63.98 millionOptionable

Recent News About These Companies

Microbot Medical's (MBOT) "Buy" Rating Reiterated at B. Riley Financial
Microbot Medical (NASDAQ:MBOT) Issues Earnings Results
New Strong Buy Stocks for July 23rd

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
HeartBeam stock logo

HeartBeam NASDAQ:BEAT

$0.50 +0.00 (+0.14%)
Closing price 08/17/2026 04:00 PM Eastern
Extended Trading
$0.50 +0.01 (+1.00%)
As of 06:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

Kewaunee Scientific stock logo

Kewaunee Scientific NASDAQ:KEQU

$36.32 -0.19 (-0.52%)
Closing price 08/17/2026 04:00 PM Eastern
Extended Trading
$36.32 +0.00 (+0.00%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

Pulmonx stock logo

Pulmonx NASDAQ:LUNG

$2.23 -0.19 (-7.85%)
Closing price 08/17/2026 04:00 PM Eastern
Extended Trading
$2.23 0.00 (0.00%)
As of 05:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$1.51 -0.04 (-2.58%)
Closing price 08/17/2026 04:00 PM Eastern
Extended Trading
$1.50 -0.01 (-0.33%)
As of 06:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.